Bridging the Gap between HPLC and UPLC Performance, System is
Favorite of QC Laboratories Testing Small Molecule Pharmaceuticals
MILFORD, Mass.--(BUSINESS WIRE)--Oct. 4, 2016--
Today, Waters Corporation (NYSE:WAT) announced that its ACQUITY®
Arc™ System received a 2016 New Product Innovation Award from market
research and growth consulting firm Frost & Sullivan.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20161004005211/en/
Waters ACQUITY Arc System, a favorite of quality control laboratories the world over, has received a New Product Innovation Award from Frost & Sullivan. (Photo: Business Wire)
The Waters®
ACQUITY Arc System is a liquid chromatograph (LC) that gives drug
development and quality control laboratories running routine,
established LC methods a single LC platform for replicating or improving
the performance of their separations methods regardless of the LC
platform on which they were first developed.
Until its introduction in 2015, scientists working with established
methods, and who wished to improve the performance of those methods, did
not have a liquid chromatograph versatile enough to bridge the gap
between high performance liquid chromatography (HPLC) and
UltraPerformance LC® (UPLC®). With the
introduction of the ACQUITY Arc System, and its enabling Arc Multi-flow
path™ technology, scientists are now able to emulate the gradient dwell
volume and mixing behavior of liquid chromatographs from a variety of
manufacturers without altering the method’s gradient table.
Waters formally introduced the ACQUITY Arc System in 2015 at a news
conference in Beijing, China.
Janani Balasundar, Research Analyst at Frost & Sullivan, noted, “In the
regulated environment in which pharmaceutical companies operate, they
are by nature conservative when it comes to adopting new technologies,
and they prefer “tried and true” methods especially when it comes to
later stages of the drug development and commercialization process.”
Janani continued, “With the ACQUITY Arc System, Waters has given
pharmaceutical companies the capability of introducing a single LC
platform for their workflows for improving analytical method performance
and thereby productivity while maintaining CGMP compliance.”
“On behalf of the ACQUITY Arc product team, we are thankful to Frost &
Sullivan for this honor,” said Mike Yelle, Vice President – Separations,
Waters Corporation. “The award recognizes the commercial success of the
ACQUITY Arc System and the positive impact it is having on laboratories,
in Asia and elsewhere, that are supporting business-critical analytical
methods.”
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration
with clients to leverage visionary innovation that addresses the global
challenges and related growth opportunities that will make or break
today's market participants.
Our “Growth Partnership” supports clients by addressing these
opportunities and incorporating two key elements driving visionary
innovation: The Integrated Value Proposition and The Partnership
Infrastructure.
• The Integrated Value Proposition provides support to our clients
throughout all phases of their journey to visionary innovation
including: research, analysis, strategy, vision, innovation and
implementation.
• The Partnership Infrastructure is entirely unique as it constructs the
foundation upon which visionary innovation becomes possible. This
includes our 360 degree research, comprehensive industry coverage,
career best practices as well as our global footprint of more than 40
offices.
For more than 50 years, we have been developing growth strategies for
the global 1000, emerging businesses, the public sector and the
investment community. Is your organization prepared for the next
profound wave of industry convergence, disruptive technologies,
increasing competitive intensity, Mega Trends, breakthrough best
practices, changing customer dynamics and emerging economies?
Contact us: Start
the discussion
About Waters Corporation (www.waters.com)
Waters Corporation (NYSE:WAT) develops and manufactures advanced
analytical and material science technologies for laboratory dependent
organizations. For more than 50 years, the company has pioneered a
connected portfolio of separations science, laboratory information
management, mass spectrometry, and thermal analysis systems.
Waters, ACQUITY, UPLC, Arc Multi-Flow Path, UltraPerformance LC and
ACQUITY Arc are trademarks of Waters Corporation.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161004005211/en/
Source: Waters Corporation
Waters Corporation
Brian J. Murphy, 508-482-2614
Public
Relations Manager
brian_j_murphy@waters.com